Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinical experience with artificial liver support systems.

P P Ting1, A A Demetriou

  • 1Cedars Sinai Medical Center, Los Angeles, CA 90048, USA.

Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|December 8, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Development and testing of a bioartificial liver.

Surgical technology international·2015
Same author

Liver repopulation with bone marrow derived cells improves the metabolic disorder in the Gunn rat.

Gut·2007
Same author

Hepatic assist devices.

Panminerva medica·2005
Same author

Serum bile acids in patients with liver failure supported with a bioartificial liver.

Alimentary pharmacology & therapeutics·2002
Same author

Activation of hepatic stellate cells in liver tissue of patients with fulminant liver failure after treatment with bioartificial liver.

Human pathology·2002
Same author

Isolation, characterization, and transplantation of bone marrow-derived hepatocyte stem cells.

Biochemical and biophysical research communications·2001

Fulminant hepatic failure (FHF) is a severe condition with high mortality. Artificial liver support systems offer a potential bridge to transplantation or native liver regeneration, improving patient survival.

Area of Science:

  • Hepatology
  • Biomedical Engineering
  • Regenerative Medicine

Background:

  • Fulminant hepatic failure (FHF) presents a critical medical challenge with high mortality rates despite advances in treatment.
  • Orthotopic liver transplantation (OLT) is the primary life-saving intervention for FHF, but donor organ scarcity limits its accessibility.
  • A significant proportion of FHF patients succumb to the disease awaiting a suitable liver graft.

Observation:

  • The limited availability of donor organs for liver transplantation necessitates alternative therapeutic strategies for FHF.
  • Research efforts are focused on developing supportive systems to sustain patients until native liver recovery or transplantation.
  • Various approaches, including biological, artificial, and bioartificial methods, are being explored to enhance survival in liver failure.

Related Experiment Videos

Findings:

  • This review examines the historical development and current status of artificial liver support (ALS) technologies.
  • The article provides an overview of the state-of-the-art in artificial liver support systems.
  • Future directions and potential advancements in ALS are discussed.

Implications:

  • Artificial liver support systems hold promise for bridging the gap between FHF diagnosis and definitive treatment (transplantation or regeneration).
  • Advancements in ALS could significantly reduce mortality associated with liver failure by providing crucial time for recovery or donor organ availability.
  • Further development of these technologies is essential to address the unmet clinical need in managing FHF patients.